Can GLP-1 treatments be combined with other weight loss methods
According to the medicine's information leaflet, patients might experience headaches, dizziness, nausea, or a general feeling of being unwell
Not for human or animal consumption, clinical, therapeutic, cosmetic, or veterinary use
Subsequently, beneficial effects of FOXO4-DRI have been demonstrated in various age-related models 6,7,8
The FDA label for tirzepatide includes cautions about use in patients with severe gastroparesis, which may further increase perioperative risk
The combination of tirzepatide and phentermine has not been adequately studied in controlled trials, making it difficult to predict outcomes or manage risks appropriately